{arrow_up} Back to top

Risk Minimisation Materials

Search by company, common medicine name, or title of Risk Minimisation Material

0-9 ABCDEFGHIJKLMNOPQRSTUVWXYZ

Darzalex

Janssen-Cilag Ltd (a Johnson & Johnson Company)

{pdf_link}

HCPs-_Important information on safety and risk minimisation of Daratumumab and interference with Blood Compatability Testing

{healthcare_pro_orange} For Healthcare Professionals

Inform health care professionals of the interference of Darzalex (daratumumab) with antibody screening and crossmatching

{pdf_link}

Important Information about Blood Transfusions

Card for patient's receiving Darzalex (daratumumab)- patient should carry this card while receiving treatment and for 6 months after treatment has ended.

{pdf_link}

Important information on safety and risk minimisation of Daratumumab and Interference with Blood Compatibility Testing

{healthcare_pro_orange} For Healthcare Professionals

Information for Blood Banks on the intereference with Antiglobulin Test _blood typing

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.